HYDROQUINONE cream

Χώρα: Ηνωμένες Πολιτείες

Γλώσσα: Αγγλικά

Πηγή: NLM (National Library of Medicine)

Αγόρασέ το τώρα

Κατεβάστε Αρχείο Π.Χ.Π. (SPC)
15-01-2018

Δραστική ουσία:

HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE)

Διαθέσιμο από:

Perrigo New York Inc

INN (Διεθνής Όνομα):

HYDROQUINONE

Σύνθεση:

HYDROQUINONE 40 mg in 1 g

Τρόπος διάθεσης:

PRESCRIPTION DRUG

Καθεστώς αδειοδότησης:

unapproved drug other

Αρχείο Π.Χ.Π.

                                HYDROQUINONE- HYDROQUINONE CREAM
PERRIGO NEW YORK INC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
HYDROQUINONE USP, 4%
SKIN BLEACHING CREAM
RX ONLY
FOR EXTERNAL USE ONLY
NOT FOR OPHTHALMIC USE
DESCRIPTION
Each gram of Hydroquinone USP, 4% Skin Bleaching Cream contains 40 mg
hydroquinone USP, in a
vanishing cream base of glyceryl monostearate, mineral oil, PEG-25
propylene glycol stearate,
polyoxyl 40 stearate, propylene glycol, propylparaben, purified water,
sodium metabisulfite, squalane
and stearic acid. Chemically, hydroquinone is C H O and has a
molecular weight of 110.11.
The chemical name is 1,4 dihydroxybenzene, and the structural formula
of hydroquinone is:
CLINICAL PHARMACOLOGY
Topical application of hydroquinone produces a reversible
depigmentation of the skin by inhibition of
the enzymatic oxidation of tyrosine to 3,4-dihydroxyphenylalanine
(dopa) (Denton, C. et al., 1952) and
suppression of other melanocyte metabolic processes (Jimbow, K. et
al., 1974) . Exposure to sunlight
or ultraviolet light will cause repigmentation of bleached areas
(Parrish, J.A. et al., 1978) .
INDICATIONS AND USAGE
Hydroquinone USP, 4% Skin Bleaching Cream is indicated for the gradual
bleaching of
hyperpigmented skin conditions such as chloasma, melasma, freckles,
senile lentigines, and other
unwanted areas of melanin hyperpigmentation.
CONTRAINDICATIONS
Prior history of sensitivity or allergic reaction to hydroquinone or
to any of the ingredients of the
product. The safety of topical hydroquinone use during pregnancy or
for children (12 years and under)
has not been established.
WARNINGS
6
6
2
1
2
3
Contains sodium metabisulfite, a sulfite that may cause allergic-type
reactions including anaphylactic
symptoms and life-threatening or less severe asthmatic episodes in
certain susceptible people. The
overall prevalence of sulfite sensitivity in the general population is
unknown
                                
                                Διαβάστε το πλήρες έγγραφο
                                
                            

Αναζήτηση ειδοποιήσεων που σχετίζονται με αυτό το προϊόν

Προβολή ιστορικού εγγράφων